Alan A Musso insider trades: Bellicum Pharmaceuticals (BLCM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2018 | BLCM | ↓ Sell | 6,206 | $7.97 | $49K | Direct | May 29, 2018 (4d) |
| Dec 11, 2017 | BLCM | ↓ Sell | 17,117 | $9.33 | $160K | Direct | Dec 13, 2017 (2d) |
| Nov 27, 2017 | BLCM | ↓ Sell | 6,206 | $9.89 | $61K | Direct | Nov 29, 2017 (2d) |
| May 25, 2017 | BLCM | ↓ Sell | 6,311 | $12.24 | $77K | Direct | May 26, 2017 (1d) |
| Nov 28, 2016 | BLCM | ↓ Sell | 29,300 | $19.51 | $572K | Direct | Nov 29, 2016 (1d) |
| Nov 24, 2015 | BLCM | ↓ Sell | 29,300 | $22.34 | $654K | Direct | Nov 27, 2015 (3d) |
| Jun 7, 2011 | TRGT | ↓ Sell | 30,875 | $21.80 | $673K | Direct | Jun 8, 2011 (1d) |
| Dec 22, 2010 | TRGT | ↓ Sell | 20,416 | $26.58 | $543K | Direct | Dec 23, 2010 (1d) |
| Oct 28, 2010 | TRGT | ↓ Sell | 3,500 | $24.63 | $86K | Direct | Oct 28, 2010 (0d) |
| Oct 25, 2010 | TRGT | ↓ Sell | 9,100 | $24.69 | $225K | Direct | Oct 26, 2010 (1d) |
| May 18, 2010 | TRGT | ↓ Sell | 12,206 | $24.36 | $297K | Direct | May 19, 2010 (1d) |
| Dec 16, 2009 | TRGT | ↓ Sell | 12,809 | $22.30 | $286K | Direct | Dec 17, 2009 (1d) |
| Dec 11, 2009 | TRGT | ↓ Sell | 37,223 | $21.53 | $801K | Direct | Dec 15, 2009 (4d) |
| Sep 4, 2009 | TRGT | ↓ Sell | 8,000 | $15.07 | $121K | Direct | Sep 9, 2009 (5d) |
| Aug 31, 2009 | TRGT | ↓ Sell | 6,000 | $14.50 | $87K | Direct | Sep 1, 2009 (1d) |
| Aug 24, 2009 | TRGT | ↓ Sell | 2,500 | $13.55 | $34K | Direct | Aug 26, 2009 (2d) |
| Aug 14, 2009 | TRGT | ↓ Sell | 4,500 | $13.51 | $61K | Direct | Aug 17, 2009 (3d) |
| Aug 7, 2009 | TRGT | ↓ Sell | 5,700 | $12.03 | $69K | Direct | Aug 11, 2009 (4d) |
| Jul 29, 2009 | TRGT | ↓ Sell | 5,263 | $11.29 | $59K | Direct | Jul 31, 2009 (2d) |
| Jul 28, 2009 | TRGT | ↓ Sell | 3,037 | $11.02 | $33K | Direct | Jul 30, 2009 (2d) |
| Aug 15, 2008 | TRGT | ↓ Sell | 600 | $10.00 | $6K | Direct | Aug 19, 2008 (4d) |
| Aug 14, 2008 | TRGT | ↓ Sell | 9,400 | $10.00 | $94K | Direct | Aug 15, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alan A Musso's insider trades
Alan A Musso is CFO and Treasurer at Bellicum Pharmaceuticals (BLCM). Since Aug 14, 2008, Alan has reported no open-market purchases and 22 sales worth $5.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (25 filings), option exercises (17 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLCM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.